Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets
New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease
Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production
Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate
Cumberland Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 4, 2014
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014
Synageva BioPharma Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa
Global Ebola Virus Vaccine Market & Pipeline Insight: 2014 Report
Amgen Statement Regarding Third Point Investment
Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT
Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 6 of Consumer Watchdog Campaign Series
MiMedx Provides Update On Outstanding Patent Litigation
Ameritox and Ingenuity Health Expand Effort to Help Assess Medication Adherence in those with Serious Mental Illness
London Eye Hospital Pharma Announces US Clinical Introduction of iolAMD™
The Leukemia & Lymphoma Society Announces Recipients of Grants Supporting New Drug Discovery
UCSF Medical Center Adopts Hi-Tech "Smart" Dressing for Chronic Wounds
Kaiser Permanente's Mail-Order Pharmacy Ranked Highest in Customer Satisfaction by J.D. Power for 6th Year in Row
Uncommon Vision: A Conversation with Ophthalmologist, Entrepreneur and Investor Jack Kavanaugh
Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express
Equities Updates on Pharma Industry - Mylan, Horizon Pharma, Hospira, VIVUS, and Endocyte
BioClinica Announces User Conferences in Europe and US
RRD International Hires Brian R. Gallagher as Senior Vice President and Chief Financial Officer
MabVax Therapeutics Nominates The Fully Human Antibody HuMab 5B1 As The Company's Lead Clinical Development Candidate
SRI International Opens Clinical Trial Unit in Michigan Life Science Innovation Center
TWi Biotechnology Receives Orphan Drug Designation for its Lead Drug Candidate AC-201 in United States
Global Hospital Pharmaceuticals Market Expected to Reach USD 11.6 Billion in 2020: Transparency Market Research
Pan's Ink and Michigan Hemp Co Team Up to Deliver Terpene-Infused Hemp CBD Products
U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination
TrialScope Appoints Richard Aguinaldo as Chief Financial Officer
ISTO Technologies to Present at 12th Annual 2014 Musculoskeletal New Ventures Conference
Boehringer Ingelheim initiates global Phase III study investigating nintedanib in patients with colorectal cancer
Reckitt Benckiser Pharmaceuticals Inc. Announces Plans to Rebrand Under Indivior PLC Following Demerger
BioSpecifics Technologies Corp. Announces FDA Approval of sBLA for XIAFLEX® for the Concurrent Treatment of Two Dupuytren's Contracture Cords
West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
WuXi PharmaTech Schedules Third-Quarter 2014 Earnings Release
Novartis teams up with multiple sclerosis advocate and musician David Osmond to launch MS education initiative Our Voice in Song™
Omeros Provides Update on PDE10 Inhibitor Program
Dyslipidemia Market Epidemiology 2023 Forecasts Report
Sinovac to Participate in Jefferies 4th Annual Asia Summit
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria
Marken Expands Cold Chain Capacity To Meet Growing Demand
China Heparin Industry 2014-2017 Report Forecasts Chinese Heparin API Market to Account Roughly 80% of Global Demand
Clustering Effect Translates into Major Growth for BioPharma Specialist
Maxwell Biotech Portfolio Company Hepatera Announces Proof-of-Concept Clinical Results with Myrcludex B, a Novel Entry Inhibitor for Treatment of Chronic Hepatitis B and Delta
Pharmacovigilance and Related Developments: Industry and Market Analysis 2014-2024
Antiemetic Drugs: World Industry and Market Analysis 2014-2024
Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024
AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients
Announcement Of Termination Of Proposed AbbVie And Shire Transaction

< Prev Next >
PR Newswire - United Business Media